Chiung-Kuei Huang1, Tunan Yu1, Suzanne M de la Monte2, Jack R Wands1, Zoltan Derdak1, Miran Kim3. 1. Liver Research Center, Division of Gastroenterology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. 2. Departments of Medicine and Pathology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. 3. Liver Research Center, Division of Gastroenterology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. Electronic address: Miran_Kim@brown.edu.
Abstract
BACKGROUND & AIMS: Alcoholic liver disease (ALD) is characterized by the development of fatty liver, alcoholic hepatitis, fibrosis and cirrhosis. However, the underlying mechanism(s) associated with progression remains elusive. Pro-inflammatory cytokines have been implicated in ALD progression due to pro-apoptotic effects on hepatocytes. Wnt/β-catenin signaling recently has been shown to promote inflammation and apoptosis, suggesting that activation of this signaling pathway may modulate ALD progression. The current study was designed to test whether pharmacological activation of Wnt/β-catenin signaling altered ALD development and progression in a rat model. METHODS: Adult male Long Evans rats were fed with isocaloric liquid diets containing 0% or 37% ethanol for 8 weeks, and also treated with Wnt agonist during the last 3 weeks of the feeding regimen. Liver and blood samples were subjected to histology, TUNEL assay, immunoblot analysis, real-time quantitative PCR, and alanine transaminase (ALT) assay. RESULTS: Wnt/β-catenin signaling was negatively correlated with Foxo3A expression and reduced steatosis, cellular injury and apoptosis in ALD rats. Mutation experiments demonstrated that Foxo3A was critical for modulating these effects. Activation of Wnt/β-catenin signaling suppressed Foxo3A-induced apoptosis through upregulation of serum/glucocorticoid regulated kinase 1 (SGK1). Moreover, pharmacological restoration of Wnt/β-catenin signaling reduced ALD progression in vivo. CONCLUSIONS: Wnt/β-catenin signaling plays a protective role in ALD progression via antagonizing Foxo3A-induced apoptosis, and activation of the Wnt/β-catenin signaling cascade attenuates ALD progression.
BACKGROUND & AIMS:Alcoholic liver disease (ALD) is characterized by the development of fatty liver, alcoholic hepatitis, fibrosis and cirrhosis. However, the underlying mechanism(s) associated with progression remains elusive. Pro-inflammatory cytokines have been implicated in ALD progression due to pro-apoptotic effects on hepatocytes. Wnt/β-catenin signaling recently has been shown to promote inflammation and apoptosis, suggesting that activation of this signaling pathway may modulate ALD progression. The current study was designed to test whether pharmacological activation of Wnt/β-catenin signaling altered ALD development and progression in a rat model. METHODS: Adult male Long Evans rats were fed with isocaloric liquid diets containing 0% or 37% ethanol for 8 weeks, and also treated with Wnt agonist during the last 3 weeks of the feeding regimen. Liver and blood samples were subjected to histology, TUNEL assay, immunoblot analysis, real-time quantitative PCR, and alanine transaminase (ALT) assay. RESULTS:Wnt/β-catenin signaling was negatively correlated with Foxo3A expression and reduced steatosis, cellular injury and apoptosis in ALDrats. Mutation experiments demonstrated that Foxo3A was critical for modulating these effects. Activation of Wnt/β-catenin signaling suppressed Foxo3A-induced apoptosis through upregulation of serum/glucocorticoid regulated kinase 1 (SGK1). Moreover, pharmacological restoration of Wnt/β-catenin signaling reduced ALD progression in vivo. CONCLUSIONS:Wnt/β-catenin signaling plays a protective role in ALD progression via antagonizing Foxo3A-induced apoptosis, and activation of the Wnt/β-catenin signaling cascade attenuates ALD progression.
Authors: A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg Journal: Cell Date: 1999-03-19 Impact factor: 41.582
Authors: Xinping Tan; Jaideep Behari; Benjamin Cieply; George K Michalopoulos; Satdarshan P S Monga Journal: Gastroenterology Date: 2006-11 Impact factor: 22.682
Authors: Udayan Apte; Gang Zeng; Michael D Thompson; Peggy Muller; Amanda Micsenyi; Benjamin Cieply; Klaus H Kaestner; Satdarshan P S Monga Journal: Am J Physiol Gastrointest Liver Physiol Date: 2007-03-01 Impact factor: 4.052
Authors: Maoyin Pang; Suzanne M de la Monte; Lisa Longato; Ming Tong; Jiman He; Rajeeve Chaudhry; Kevin Duan; Jiyun Ouh; Jack R Wands Journal: J Hepatol Date: 2009-03-20 Impact factor: 25.083
Authors: Xinping Tan; Youzhong Yuan; Gang Zeng; Udayan Apte; Michael D Thompson; Benjamin Cieply; Donna B Stolz; George K Michalopoulos; Klaus H Kaestner; Satdarshan P S Monga Journal: Hepatology Date: 2008-05 Impact factor: 17.425
Authors: Chengcheng Ji; Katsuya Nagaoka; Jing Zou; Sarah Casulli; Shaolei Lu; Kevin Y Cao; Hongyu Zhang; Yoshifumi Iwagami; Rolf I Carlson; Keri Brooks; Jonathan Lawrence; William Mueller; Jack R Wands; Chiung-Kuei Huang Journal: FASEB J Date: 2018-09-06 Impact factor: 5.191